Signet-ring cell

Signet-ring cell carcinoma is a rare form of cancer that derives its name from the appearance of the tumor cells. These cells are characterized by a large vacuole that displaces the nucleus to the periphery, giving the cell a resemblance to a signet ring. This type of carcinoma can occur in various parts of the body but is most commonly found in the stomach, making it a significant subtype of gastric cancer. It is also seen in the colon, breast, ovary, and pancreas. Due to its aggressive nature and tendency to metastasize early, the prognosis for signet-ring cell carcinoma is generally poor compared to other types of cancer.

Etiology and Pathogenesis

The exact cause of signet-ring cell carcinoma is not well understood, but it is believed to involve a combination of genetic and environmental factors. In the stomach, for instance, chronic inflammation caused by Helicobacter pylori infection is a known risk factor. Genetic mutations, such as those affecting the E-cadherin gene, have also been implicated in the development of this cancer, particularly in familial cases of gastric signet-ring cell carcinoma.

Clinical Presentation

Symptoms of signet-ring cell carcinoma vary depending on the organ affected but often include nonspecific signs such as weight loss, fatigue, and pain. In gastric cases, patients may experience abdominal discomfort, nausea, vomiting, and early satiety. Due to its aggressive nature, signet-ring cell carcinoma may rapidly progress to advanced stages before diagnosis.

Diagnosis

Diagnosis of signet-ring cell carcinoma typically involves a combination of imaging studies, such as CT scans or MRIs, and histological examination of tissue samples obtained through biopsy. The presence of characteristic signet-ring cells in the biopsy specimen is key to the diagnosis. Additional tests, including molecular and genetic studies, may be performed to further characterize the tumor and guide treatment decisions.

Treatment

Treatment of signet-ring cell carcinoma depends on the location and stage of the disease but often includes a combination of surgery, chemotherapy, and radiation therapy. In gastric signet-ring cell carcinoma, for example, surgical removal of the stomach (gastrectomy) may be necessary. Chemotherapy regimens typically involve drugs that are known to be effective against this type of cancer, but the response rates are generally lower than for other types of carcinoma.

Prognosis

The prognosis for patients with signet-ring cell carcinoma is generally poor, with lower survival rates compared to other carcinomas. This is due in part to the cancer's tendency to be diagnosed at a later stage and its resistance to conventional treatments. Early detection and aggressive treatment are critical for improving outcomes.

Epidemiology

Signet-ring cell carcinoma is relatively rare, accounting for a small percentage of all carcinomas. However, its incidence varies by organ and region, with gastric signet-ring cell carcinoma being more common in East Asia due to higher rates of Helicobacter pylori infection and certain dietary factors.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian